ATE158181T1 - Transdermale therapeutische systeme mit kristallisationsinhibitoren - Google Patents
Transdermale therapeutische systeme mit kristallisationsinhibitorenInfo
- Publication number
- ATE158181T1 ATE158181T1 AT92922822T AT92922822T ATE158181T1 AT E158181 T1 ATE158181 T1 AT E158181T1 AT 92922822 T AT92922822 T AT 92922822T AT 92922822 T AT92922822 T AT 92922822T AT E158181 T1 ATE158181 T1 AT E158181T1
- Authority
- AT
- Austria
- Prior art keywords
- transdermal therapeutic
- crystalization
- inhibitors
- therapeutic systems
- systems
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4136057 | 1991-10-31 | ||
| DE4210711A DE4210711A1 (de) | 1991-10-31 | 1992-03-27 | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE158181T1 true ATE158181T1 (de) | 1997-10-15 |
Family
ID=25908725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92922822T ATE158181T1 (de) | 1991-10-31 | 1992-10-21 | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0610357B1 (https=) |
| JP (1) | JP3526864B2 (https=) |
| AT (1) | ATE158181T1 (https=) |
| AU (2) | AU2895392A (https=) |
| CA (1) | CA2120599C (https=) |
| DE (2) | DE4210711A1 (https=) |
| DK (1) | DK0610357T3 (https=) |
| ES (1) | ES2106888T3 (https=) |
| FI (1) | FI110061B (https=) |
| GR (1) | GR3025237T3 (https=) |
| HU (1) | HU227531B1 (https=) |
| NO (1) | NO307644B1 (https=) |
| PT (1) | PT101019B (https=) |
| WO (1) | WO1993008795A1 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5919478A (en) * | 1993-06-25 | 1999-07-06 | Alza Corporation | Incorporating poly-N-vinyl amide in a transdermal system |
| DE4333595A1 (de) * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut |
| DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
| DE4429667C2 (de) * | 1994-08-20 | 1996-07-11 | Lohmann Therapie Syst Lts | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
| US6024974A (en) * | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
| IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
| DE19500662C2 (de) * | 1995-01-12 | 2001-04-26 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster und seine Verwendung |
| US5698217A (en) * | 1995-05-31 | 1997-12-16 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device containing a desiccant |
| CA2222133C (en) † | 1995-06-07 | 2002-12-24 | Cygnus, Inc. | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
| US5702720A (en) * | 1995-12-22 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of flurbiprofen |
| DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
| DE19649535C2 (de) * | 1996-11-29 | 2000-02-10 | Lohmann Therapie Syst Lts | Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems |
| DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
| GB9720470D0 (en) * | 1997-09-25 | 1997-11-26 | Ethical Pharmaceuticals South | Inhibition of crystallization in transdermal devices |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| DE19829713C1 (de) * | 1998-07-03 | 2000-01-05 | Lohmann Therapie Syst Lts | Therapeutisches System mit Zusatz von Perglanzpigmenten |
| DE19834006A1 (de) * | 1998-07-29 | 2000-02-24 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen |
| DE19843027A1 (de) * | 1998-09-19 | 2000-03-23 | Labtec Gmbh | Neohesperidin DC als Kristallisationsinhibitor |
| EP1233763B1 (de) * | 1999-11-29 | 2003-07-30 | LTS Lohmann Therapie-Systeme AG | Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung |
| DE10012908B4 (de) * | 2000-03-16 | 2005-03-17 | Lts Lohmann Therapie-Systeme Ag | Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| IL159415A0 (en) * | 2001-06-18 | 2004-06-01 | Noven Pharma | Enhanced drug delivery in transdermal systems |
| DK1670433T3 (da) | 2003-10-10 | 2012-03-12 | Ferring Bv | Transdermal farmaceutisk formulering til mindskelse af hudrester |
| EP1857103B1 (en) | 2005-02-28 | 2018-10-24 | Hisamitsu Pharmaceutical Co., Inc. | Transdermally absorbable preparation |
| EP2258369B1 (en) | 2008-02-27 | 2015-04-08 | Hisamitsu Pharmaceutical Co., Inc. | Medicated patch |
| JP5546013B2 (ja) | 2008-02-27 | 2014-07-09 | 久光製薬株式会社 | 貼付剤及び包装体 |
| EP2258396B1 (en) | 2008-03-03 | 2017-09-06 | Hisamitsu Pharmaceutical Co., Inc. | Transdermally absorbable preparation |
| JP5766475B2 (ja) * | 2010-03-30 | 2015-08-19 | 日東電工株式会社 | 貼付製剤およびその製造方法 |
| DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
| WO2015037639A1 (ja) * | 2013-09-11 | 2015-03-19 | 株式会社 メドレックス | テープ剤の新規な基剤組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8512358D0 (en) * | 1985-05-16 | 1985-06-19 | Euro Celtique Sa | Transdermal delivery system |
| IL86211A (en) * | 1987-05-04 | 1992-03-29 | Ciba Geigy Ag | Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation |
| DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
| WO1991005529A1 (en) * | 1989-10-13 | 1991-05-02 | Watson Laboratories, Inc. | Drug delivery systems and matrix therefor |
| JPH07116032B2 (ja) * | 1990-04-06 | 1995-12-13 | 積水化学工業株式会社 | ニトログリセリン貼付剤 |
-
1992
- 1992-03-27 DE DE4210711A patent/DE4210711A1/de not_active Withdrawn
- 1992-10-21 AT AT92922822T patent/ATE158181T1/de active
- 1992-10-21 DK DK92922822.9T patent/DK0610357T3/da active
- 1992-10-21 WO PCT/EP1992/002478 patent/WO1993008795A1/de not_active Ceased
- 1992-10-21 ES ES92922822T patent/ES2106888T3/es not_active Expired - Lifetime
- 1992-10-21 JP JP50815093A patent/JP3526864B2/ja not_active Expired - Lifetime
- 1992-10-21 EP EP92922822A patent/EP0610357B1/de not_active Expired - Lifetime
- 1992-10-21 CA CA002120599A patent/CA2120599C/en not_active Expired - Lifetime
- 1992-10-21 DE DE59208918T patent/DE59208918D1/de not_active Expired - Lifetime
- 1992-10-21 AU AU28953/92A patent/AU2895392A/en not_active Abandoned
- 1992-10-29 PT PT101019A patent/PT101019B/pt not_active IP Right Cessation
- 1992-11-23 HU HU9401257A patent/HU227531B1/hu unknown
-
1994
- 1994-04-29 NO NO941593A patent/NO307644B1/no not_active IP Right Cessation
- 1994-04-29 FI FI942011A patent/FI110061B/fi not_active IP Right Cessation
-
1997
- 1997-03-25 AU AU16529/97A patent/AU712692B2/en not_active Expired
- 1997-10-31 GR GR970402873T patent/GR3025237T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0610357B1 (de) | 1997-09-17 |
| JPH07506083A (ja) | 1995-07-06 |
| HUT72964A (en) | 1996-06-28 |
| GR3025237T3 (en) | 1998-02-27 |
| PT101019B (pt) | 1999-10-29 |
| AU712692B2 (en) | 1999-11-11 |
| DE4210711A1 (de) | 1993-05-06 |
| EP0610357A1 (de) | 1994-08-17 |
| NO941593D0 (https=) | 1994-04-29 |
| AU2895392A (en) | 1993-06-07 |
| WO1993008795A1 (de) | 1993-05-13 |
| HU9401257D0 (en) | 1994-08-29 |
| NO307644B1 (no) | 2000-05-08 |
| JP3526864B2 (ja) | 2004-05-17 |
| ES2106888T3 (es) | 1997-11-16 |
| CA2120599C (en) | 2003-04-15 |
| AU1652997A (en) | 1997-05-29 |
| PT101019A (pt) | 1994-02-28 |
| HU227531B1 (en) | 2011-07-28 |
| FI942011L (fi) | 1994-04-29 |
| CA2120599A1 (en) | 1993-05-13 |
| DK0610357T3 (da) | 1998-05-11 |
| DE59208918D1 (de) | 1997-10-23 |
| FI942011A0 (fi) | 1994-04-29 |
| NO941593L (no) | 1994-04-29 |
| FI110061B (fi) | 2002-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE158181T1 (de) | Transdermale therapeutische systeme mit kristallisationsinhibitoren | |
| DE59208408D1 (de) | Transdermale therapeutische systeme | |
| ATE200028T1 (de) | Transdermale abgabe vorrichtung | |
| DE69524436D1 (de) | Verbesserte transdermale vorrichtung mit verringerter delaminierung | |
| DE59507188D1 (de) | Transdermale therapeutische systeme enthaltend sexualsteroide | |
| DK0817622T3 (da) | Transdermalt applicerbart lægemiddel med ACE-hæmmere | |
| FI961282L (fi) | Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena | |
| NO950047L (no) | Transdermalt terapeutisk system inneholdende det aktive stoffet 17-beta-östradiol | |
| DK0794770T3 (da) | Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning | |
| DE68917651D1 (de) | Aktiv-Matrix-Anzeigevorrichtung. | |
| NO993855L (no) | Töyelig transdermalt terapeutisk system | |
| DE59712215D1 (de) | Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination | |
| ES1025196Y (es) | Dispositivo suministrador de cinta adhesiva. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEFA | Change of the company name |